Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers
Condition: Clear Renal Cell Cancer (< 7cm Size)
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT03694912
Sponsor: Yonsei University
Phase:
Eligibility:
- Age: minimum 20 Years maximum N/A
- Gender: All
Inclusion Criteria:
- Patients diagnosed as clear cell renal cell caner T1 stage
- Patients who have undergone partial or radical nephrectomy in Severance Hospital, Sinchon from 2018.11 and 2019.10
- Those who agree to give permission to use their human source information
- Those who agree with this study
Exclusion Criteria:
- Vulnerable Participants
- Those who don't agree with this study
View trial on ClinicalTrials.gov